Compare, Analyse Panacea Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs354377-   
Low Rs138272-   
Sales per share (Unadj.) Rs74.6112.1-  
Earnings per share (Unadj.) Rs6.7-28.3-  
Cash flow per share (Unadj.) Rs15.5-23.4-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs57.288.0-  
Shares outstanding (eoy) m61.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.9 114.0%   
Avg P/E ratio x36.8-11.5 -320.6%  
P/CF ratio (eoy) x15.9-13.9 -114.5%  
Price / Book Value ratio x4.33.7 116.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,06154,766 27.5%   
No. of employees `0002.34.3 53.9%   
Total wages/salary Rs m1,4713,437 42.8%   
Avg. sales/employee Rs Th1,973.64,409.0 44.8%   
Avg. wages/employee Rs Th635.6800.7 79.4%   
Avg. net profit/employee Rs Th176.8-1,111.0 -15.9%   
INCOME DATA
Net Sales Rs m4,56718,928 24.1%  
Other income Rs m45133 33.8%   
Total revenues Rs m4,61219,061 24.2%   
Gross profit Rs m2,030-3,280 -61.9%  
Depreciation Rs m540817 66.1%   
Interest Rs m1,048513 204.5%   
Profit before tax Rs m486-4,477 -10.9%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77280 27.6%   
Profit after tax Rs m409-4,769 -8.6%  
Gross profit margin %44.4-17.3 -256.5%  
Effective tax rate %15.9-6.2 -253.8%   
Net profit margin %9.0-25.2 -35.5%  
BALANCE SHEET DATA
Current assets Rs m2,41513,863 17.4%   
Current liabilities Rs m9,0777,800 116.4%   
Net working cap to sales %-145.932.0 -455.4%  
Current ratio x0.31.8 15.0%  
Inventory Days Days65111 58.7%  
Debtors Days Days71124 57.2%  
Net fixed assets Rs m8,3338,081 103.1%   
Share capital Rs m6188 69.8%   
"Free" reserves Rs m3,4430-   
Net worth Rs m3,50414,856 23.6%   
Long term debt Rs m4615,221 8.8%   
Total assets Rs m13,75528,065 49.0%  
Interest coverage x1.5-7.7 -18.9%   
Debt to equity ratio x0.10.4 37.5%  
Sales to assets ratio x0.30.7 49.2%   
Return on assets %10.6-15.2 -69.9%  
Return on equity %11.7-32.1 -36.4%  
Return on capital %38.7-19.8 -195.4%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Net fx Rs m7360-   
CASH FLOW
From Operations Rs m1,0491,616 64.9%  
From Investments Rs m-54-496 10.8%  
From Financial Activity Rs m-1,0114,738 -21.3%  
Net Cashflow Rs m-205,858 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.2 Rs / ZAR

Compare PANACEA BIOTECH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: ALEMBIC  TTK HEALTHCARE  PFIZER  WYETH  CADILA HEALTHCARE  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PANACEA BIOTECH SHARE PRICE


May 14, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS